This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Jul 29;356(9227):352-3.

doi: 10.1016/S0140-6736(00)02521-6.

Differences between blood-pressure-lowering drugs

S MacMahon¹, B Neal

Affiliations

PMID: 10972362
DOI: 10.1016/S0140-6736(00)02521-6

Comment

Differences between blood-pressure-lowering drugs

S MacMahon et al. Lancet. 2000.

. 2000 Jul 29;356(9227):352-3.

doi: 10.1016/S0140-6736(00)02521-6.

Authors

S MacMahon¹, B Neal

Affiliation

¹ Institute for International Health, University of Sydney, NSW, Australia.

PMID: 10972362
DOI: 10.1016/S0140-6736(00)02521-6

No abstract available

PubMed Disclaimer

Comment in

INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Achard JM, Oudart N, Aldigier JC. Achard JM, et al. Lancet. 2000 Dec 2;356(9245):1926-7; author reply 1928-9. Lancet. 2000. PMID: 11130401 No abstract available.
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Fournier A, Georgita A, Bouffandeau B, Oprisiu R. Fournier A, et al. Lancet. 2000 Dec 2;356(9245):1927; author reply 1928-9. doi: 10.1016/s0140-6736(05)73476-0. Lancet. 2000. PMID: 11130405 No abstract available.

Comment on

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE. Hansson L, et al. Lancet. 2000 Jul 29;356(9227):359-65. doi: 10.1016/s0140-6736(00)02526-5. Lancet. 2000. PMID: 10972367 Clinical Trial.
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
Brown MJ, Palmer CR, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM. Brown MJ, et al. Lancet. 2000 Jul 29;356(9227):366-72. doi: 10.1016/S0140-6736(00)02527-7. Lancet. 2000. PMID: 10972368 Clinical Trial.

Similar articles

Blood-pressure-lowering treatment.
Pahor M, Psaty BM, Alderman MH, Applegate WB, Furberg CD. Pahor M, et al. Lancet. 2001 Jul 14;358(9276):152-3. doi: 10.1016/S0140-6736(01)05362-4. Lancet. 2001. PMID: 11469244 No abstract available.
[Hypertension in the elderly].
Ogihara T. Ogihara T. Nihon Rinsho. 2004 Mar;62 Suppl 3:394-8. Nihon Rinsho. 2004. PMID: 15171406 Review. Japanese. No abstract available.
Effects of different blood-pressure-lowering regimens on major cardiac events.
Steffen HM, Toex U, Kolloch R. Steffen HM, et al. Lancet. 2004 Jan 24;363(9405):331; author reply 331-2. doi: 10.1016/S0140-6736(03)15403-7. Lancet. 2004. PMID: 14751718 No abstract available.
Cardiovascular outcomes and antihypertensive drug treatment in older women.
Staessen JA, Thijs L, Wang J, Li Y. Staessen JA, et al. JAMA. 2005 Apr 6;293(13):1588; author reply 1588-9. doi: 10.1001/jama.293.13.1588-a. JAMA. 2005. PMID: 15811972 No abstract available.
[Drug therapy of arterial hypertension. Results of new intervention studies].
Hausberg M, Kosch M, Rahn KH. Hausberg M, et al. Internist (Berl). 2001 Dec;42(12):1610-8. doi: 10.1007/s001080170013. Internist (Berl). 2001. PMID: 11793600 Review. German. No abstract available.

See all similar articles

Cited by

Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity.
Ruilope LM, Coca A, Banegas JR, Pablos JL, Luque M. Ruilope LM, et al. Curr Hypertens Rep. 2002 Aug;4(4):261-4. doi: 10.1007/s11906-996-0001-3. Curr Hypertens Rep. 2002. PMID: 12117452 Review. No abstract available.
Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.
Giles TD, Sander GE. Giles TD, et al. J Clin Hypertens (Greenwich). 2001 Nov-Dec;3(6):346-53. doi: 10.1111/j.1524-6175.2001.00469.x. J Clin Hypertens (Greenwich). 2001. PMID: 11723356 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information